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Abstract
Background: The association between anxiety and depression related traits and dyspepsia may reflect a common
genetic predisposition. Furthermore, genetic factors may contribute to the risk of having increased visceral
sensitivity, which has been implicated in dyspeptic symptom generation. Serotonin (5-HT) modulates visceral
sensitivity by its action on 5-HT3 receptors. Interestingly, a functional polymorphism in HTR3A, encoding the 5-HT3
receptor A subunit, has been reported to be associated with depression and anxiety related traits. A functional
polymorphism in the serotonin transporter (5-HTT), which terminates serotonergic signalling, was also found
associated with these psychiatric comorbidities and increased visceral sensitivity in irritable bowel syndrome, which
coexistence is associated with higher dyspeptic symptom severity. We investigated the association between these
functional polymorphisms and dyspeptic symptom severity.
Methods: Data from 592 unrelated, Caucasian, primary care patients with dyspepsia participating in a randomised
clinical trial comparing step-up and step-down antacid drug treatment (The DIAMOND trial) were analysed. Patients
were genotyped for HTR3A c.-42C > T SNP and the 44 bp insertion/deletion polymorphism in the 5-HTT promoter
(5-HTTLPR). Intensity of 8 dyspeptic symptoms at baseline was assessed using a validated questionnaire (0 = none;
6 = very severe). Sum score ≥20 was defined severe dyspepsia.
Results: HTR3A c.-42T allele carriers were more prevalent in patients with severe dyspepsia (OR 1.50, 95% CI 1.06-
2.20). This association appeared to be stronger in females (OR 2.05, 95% CI 1.25-3.39) and patients homozygous for
the long (L) variant of the 5-HTTLPR genotype (OR 2.00, 95% CI 1.01-3.94). Females with 5-HTTLPR LL genotype
showed the strongest association (OR = 3.50, 95% CI = 1.37-8.90).
Conclusions: The HTR3A c.-42T allele is associated with severe dyspeptic symptoms. The stronger association
among patients carrying the 5-HTTLPR L allele suggests an additive effect of the two polymorphisms. These results
support the hypothesis that diminished 5-HT3 mediated antinociception predisposes to increased visceral sensitivity
of the gastrointestinal tract. Moreover, the HTR3A c.-42C > T and 5-HTTLPR polymorphisms likely represent
predisposing genetic variants in common to psychiatric morbidity and dyspepsia.
Background
Dyspeptic symptoms are common in the general popula-
tion, accounting for 3-8% of the consultations in general
practice [1-3]. Although it is not a life threatening condi-
tion, dyspepsia represents a significant and costly health
problem with substantial negative impact on quality of
life and health care consumption [4,5]. A variety of dis-
tinct abnormalities in gastroduodenal motility have been
identified in subgroups of patients with dyspeptic symp-
toms. However, the correlation between the presence of
dyspeptic symptoms and gastroduodenal motor dysfunc-
tion is relatively weak [6-8]. More recently, visceral
hypersensitivity has been put forward as a mechanism
underlying dyspeptic symptoms. Visceral hypersensitivity
has been associated with the presence of dyspeptic symp-
toms [9], but others were not able to confirm this finding
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[10-12]. Furthermore, psychosocial factors and psychia-
tric morbidity are underlying risk factors for the develop-
ment of dyspeptic symptoms [13]. The most common
psychiatric comorbidities in patients with dyspepsia are
anxiety and depressive disorders [14].
Several genetic variants have been reported to affect the
risk of having dyspepsia [15-19]. The mechanism under-
lying the association with the C825T polymorphism in
the gene encoding the G protein b3 subunit remains to
be determined [15-17]. Abnormal immune response
against H. pylori is likely underlying the associations with
RANTES promoter C-28G genotype and Toll-like recep-
tor 2 -196 to -174 del carrier status [18,19]. There is evi-
dence of genetic influence on other risk factors for
dyspepsia, i.e. psychosocial factors and psychiatric mor-
bidity [20]. The association between psychosocial factors,
psychiatric morbidity and dyspepsia may reflect a com-
mon genetic predisposition. Furthermore, we hypothe-
sized that genetic factors may contribute to the risk of
having increased visceral sensitivity and (consequently)
affect the intensity of dyspepsia.
Serotonin (5-HT) plays a key role in modulating upper
gastrointestinal sensory function [21]. Besides, central
alterations in 5-HT transmission are thought to have a
role in anxiety and depression [22]. Therefore, genes of
the serotonergic system are critical candidates in assessing
the role of genetic factors in dyspeptic symptom severity.
Of special interest is the 5-HT3 receptor, as 5-HT3 recep-
tor antagonism reduces dyspeptic symptoms [23,24] and
exerts anxiolytic effects [25]. The 5-HT3 receptor is a
ligand-gated ion channel, structured as a pentameric com-
plex. In humans, five different subunit genes, HTR3A-E,
have been identified [26]. The 5-HT3A subunit seems to
play a key role in receptor formation, since it is the only
subunit that can form functional homopentamers. The
other subunits only form functional heteromers with the
5-HT3A subunit [26]. A functional polymorphism, c.-42C
> T (rs1062613), has been identified in the HTR3A gene.
The T allele promotes translation of the HTR3A transcript
resulting in enhanced production of the 5-HT3A subunit
[27,28]. It is noteworthy that the c.-42C > T polymorph-
ism has been reported associated with depressive disorder
[27], the anxiety-related trait harm avoidance [29], and
irritable bowel syndrome (IBS), a functional gastrointest-
inal disorder showing comorbidity with anxiety and
depression and patients displaying visceral hypersensitivity
[28,30].
Serotonergic signalling is terminated, peripherally and
centrally, by 5-HT transporter (5-HTT) mediated uptake.
A common polymorphism, a 44 base pair (bp) insertion/
deletion, has been described in the promoter (transcrip-
tional control region) of the 5-HTT gene. This poly-
morphism, 5-HTTLPR, creates a long (L) and a short (S)
allele [31]. Homozygosity for the short variant and
heterozygosity result in reduced transcription, less
protein expression and less reuptake of serotonin [32].
The 5-HTTLPR S allele has been found associated with
increased visceral sensitivity in IBS [33] and with depres-
sion and anxiety related traits [34,35].
Based on this information, it can be hypothesised that
polymorphisms in HTR3A and 5-HTT genes might influ-
ence the sensory processes in the upper GI tract and affect
dyspeptic symptom generation and reporting. In the pre-
sent study we aimed to investigate the association between
functional polymorphisms in these genes and dyspeptic
symptom severity in primary care patients with uninvesti-
gated dyspepsia. This association was studied in the
knowledge that psychosocial comorbidity, IBS and coping
styles should be included as potential confounders.
Methods
Study population
We performed a cross-sectional analysis of patients con-
sulting with dyspepsia included in a large multicenter ran-
domised treatment trial in primary care (DIAMOND trial).
All patients included were consulting their General Practi-
tioner with a new episode of dyspepsia, without alarm
symptoms. They represent patients with dyspepsia mana-
ged in primary care. Details of the study design have been
described elsewhere [36]. The study has been approved by
the Medical Ethics Committees of the University Medical
Centres Utrecht, Maastricht and Nijmegen.
Patients were enrolled after giving written informed
consent. All data used for this study were registered at
inclusion, before starting dyspepsia treatment. Self-
reported questionnaires regarding gastrointestinal symp-
toms, demographic data (age, gender and ethnicity)
psychopathology, life style factors; current smoker (yes/
no) and current alcohol consumption (yes/no), use of co-
medications, Irritable bowel syndrome (IBS) status (self
reported; yes/no) were obtained at baseline. One blood
sample was drawn for DNA extraction and determination
of genotypes.
Dyspeptic symptoms were classified with a dyspepsia
symptom questionnaire, validated by Veldhuyzen van
Zanten [37]. It covers eight essential dyspeptic symptoms:
epigastric pain, belching, heartburn, bloating, flatulence,
regurgitation, nausea and halitosis. Severity of symptoms
was registered on a 7 point Likert scale graded: (0) none,
(1) minimal, (2) mild, (3) moderate, (4) moderately
severe, (5) severe, (6) very severe. The symptom severity
score is calculated by the sum of all items (range 0-48).
Patients were classified as having mild, moderate and
severe symptoms based on tertiles in the mean symptom
score. Severe dyspeptic symptoms were defined as score
≥20.
Psychological problems were assessed using a validated
Dutch version of SCL-90 questionnaire consisting of
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90 questions about 9 dimensions of psychological state
[38]. In this analysis we used the SCL-90 dimension
“psycho-neuroticism” which summarizes psychic dys-
function (calculated as a sum of all questions divided by
the number of dimensions).
Coping styles were measured by a short version of the
Utrecht Coping Questionnaire consisting of 17 items
[39]. Six coping styles are distinguished, classified as:
active coping, seeking support, avoidance coping, pallia-
tive coping, religious coping and passive reaction. Coping
styles were rated on a four-point Likert scale ranging
from (1) seldom or never, (2) sometimes, (3) often and
(4) very often. Scale scores are the sums of the individual
items. Higher scores indicate that the specific coping
style is more often adopted.
Genotyping
Genomic DNA was extracted from whole blood using the
QIAamp DNA blood minikit (Qiagen, Hilden, Germany).
Genotyping of the HTR3A c.-42C > T polymorphism
(rs1062613) was performed by Molecular Beacon assay
using the iCycler iQ real-time PCR detection system
(BioRad, Hercules, CA, USA). The assay was carried out in
a total volume of 25 μl, containing 50 ng of genomic DNA,
12.5 μl 2× iQ Supermix (BioRad, Hercules, CA, USA),
1000 nM of forward primer (5’-GCAGCCTCA-
GAAGGTGTG-3’), 250 nM of reverse primer (5’-
CAGTTGAAGTCGTCGTAGCC-3’) and 400 nM of each
molecular beacon. MgCl2 was added to obtain a final con-
centration of 4 mM. Sequences of the molecular beacons
were 5’-FAM-CGGACCAGTGCTCAGGGCGAGGCGGT
CCG-DABCYL-3’ (C-allele specific) and 5’-TXR-CGC
GACCGAGTGCTCAGGACGAGGCTGGTCGCG-DAB-
CYL-3’ (T-allele specific). The PCR thermal cycling proto-
col applied consisted of an initial denaturation and
enzyme activation step of 95°C for 3 min, followed by 40
cycles of 95°C for 30 s, 60°C for 1 min and 72°C for 45 s.
In each run several controls were included: a “no tem-
plate” control to check for contamination of reagents and
positive controls for all three genotypes. To validate geno-
typing of HTR3A c.-42C > T by molecular beacon assay,
sequencing was performed in a set of randomly chosen
patients; concordance was 100%.
Genotyping of 5-HTTLPR polymorphism was per-
formed by PCR and subsequent agarose gel electrophor-
esis. PCR was performed using the primers described by
Camilleri et al [40]. The assay was carried out in a total
volume of 25 μl, containing 50 ng of genomic DNA,
12.5 μl GC buffer I, 4.0 μl dNTP mix (2.5 mM each), 200
nM of each primer and 0.25 μl TaKaRa LA Taq polymer-
ase (5 U/μl). The PCR thermal cycling protocol applied
consisted of an initial denaturation step of 94°C for
1 min, followed by 30 cycles of 94°C for 30 s, 60°C for
30 s, 72°C for 2 min and a final extension step at 72°C
for 5 min. The size of the amplified fragments was deter-
mined by electrophoresis on a 2.5% low range ultra agar-
ose gel (Biorad, Hercules, CA, USA) stained with
ethidium bromide; 572 bp and 528 bp products were
typed as long (L) and short (S) alleles respectively.
Data analysis
Severity of dyspeptic symptoms was dichotomised as a
sum score of ≥20 yes/no. Age was categorised as < 45
and ≥ 45 years.
The genotype distributions for the HTR3A c.-42C > T
and 5-HTTLPR polymorphisms were tested for Hardy-
Weinberg equilibrium using the Chi square test. In vitro
studies have revealed that both the heterozygous (LS) and
homozygous S genotypes of 5-HTTLPR result in reduced
5-HTT protein expression and uptake of serotonin [32].
Therefore, for 5-HTTLPR S allele carriers were analyzed
versus subjects with the LL genotype. The significant dif-
ference in amygdaloidal activity in subjects with CC and
CT genotypes of HTR3A c.-42C > T suggests a dominant
effect of the T allele [41]. Therefore, we have analysed the
CC genotype versus the combined homozygous and het-
erozygous T genotype.
Chi square test was used to test differences in genotype
distributions, demographic, lifestyle and biologic factors,
between patients with severe dyspepsia and mild and mod-
erate dyspepsia. To assess association between genotype
and phenotype logistic regression model with severe dys-
peptic symptoms (yes/no) as dependent variable was used.
For this model adjustments were made for age, IBS status,
psycho neuroticism, use of antidepressants, use of acid
suppressive medication and active coping style. Confound-
ing effect by gender, psycho neuroticism, 5-HTTLPR gen-
otype, alcohol use and smoking status was evaluated using
stratified analyses.
To avoid bias due to race related differences in genotype
distribution we excluded non Caucasian patients from the
analysis. To prevent bias from missing values (4-15%) due
to full or partial non response, regression method was
used to impute missing values on the items of SCL-90,
gastrointestinal symptom questionnaire, and other
covariates.
All statistical analyses were performed with SPSS for
Windows, version 14.0. P values less than the respective
significance thresholds, obtained by applying Bonferroni
correction for multiple testing, were considered statisti-
cally significant.
Results
From the 664 patients included in the DIAMOND study,
625 (94.1%) were of Caucasian origin. Blood samples for
genotyping were obtained from 592 patients (94.7%).
Between 20-30% of the patients graded their symptoms
as mild to moderate (Table 1). Patients with severe
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dyspepsia were younger (p < 0.05) and had higher level of
psycho neuroticism (p < 0.05) than patients with mild
and moderate dyspepsia (Table 2). No significant differ-
ence was observed regarding gender, smoking behaviour
and IBS co morbidity, as well as alcohol consumption
and co-medication use.
The genotype distributions of HTR3A c.-42C > T and
5-HTTLPR were in concordance with Hardy-Weinberg
equilibrium (Table 3). HTR3A c.-42T allele was more
prevalent among patients with severe dyspepsia (45.2 vs.
35.7%); the OR for association was 1.50 (95% CI 1.06-
2.20). The association did not remain significant after
Bonferroni correction for multiple testing (significance
threshold P = 0.025). There was no association of 5-
HTTLPR genotype considered as a single factor with dys-
peptic symptom severity (Table 3).
To determine whether gender, 5-HTTLPR genotype,
smoking and alcohol consumption and psycho neuroti-
cism modify the effect of HTR3A c.-42C > T genotype on
dyspeptic symptoms we stratified for these factors. A sig-
nificantly increased risk was found in females (OR 2.05,
95% CI 1.25-3.39) and in patients with 5-HTTLPR LL
genotype (OR 2.00, 95% CI 1.01-3.94) (Table 4). The
influence of female gender remained significant after
Table 1 Overview and grading of dyspeptic symptoms (%) in the study population
Symptom Absent Minimal Mild Moderate Moderately Severe Severe Very Severe
Epigastric pain 14.3 11.1 26.5 30.4 13.9 3.2 0.6
Heartburn 16.0 12.3 19.4 22.7 20.1 6.3 3.2
Regurgitation 17.2 14.1 25.3 21.5 15.1 4.7 2.1
Nausea 35.8 22.3 22.1 9.2 6.6 2.9 1.1
Bloating 14.2 13.8 23.2 21.7 19.0 6.2 2.0
Belching 12.9 16.7 25.3 21.4 15.7 5.6 2.4
Flatulence 10.2 17.8 30.7 22.0 13.7 4.5 1.1
Halitosis 42.0 25.6 16.4 8.6 3.6 2.4 1.4
Table 2 Patients characteristics according to dyspeptic symptom severity
Severe dyspeptic symptoms
Yes No
Number 197 (33.3) 395 (66.7)
Age, years < 45 108 (54.8) 151 (38.2)
≥ 45 89 (45.2) 244 (61.8)
Gender Male 84 (42.6) 186 (47.1)
Female 113 (57.4) 209 (52.9)
Current alcohol use Yes 149 (75.6) 295 (74.7)
No 48 (24.4) 100 (25.3)
Current smoking Yes 59 (29.9) 101 (25.6)
No 138 (70.1) 294 (74.4)
IBS Yes 10 (5.1) 17 (4.3)
No 187 (94.9) 378 (95.7)
Co-medication No 123 (62.4) 265 (67.0)
Antacids 47 (23.9) 68 (17.2)
NSAIDs 24 (12.2) 65 (16.4)
Antidepressants 17 (8.6) 19 (4.8)
Psycho neuroticism Yes 95 (48.2) 107 (27.1)
No 102 (51.8) 288 (72.9)
Coping style Active coping 13.9 13.3
Seeking support 11.7 11.1
Avoidance coping 3.9 3.7
Palliative coping 4.7 4.4
Religious coping 3.2 3.0
Passive reaction 2.0 2.0
Data presented as number (%) except for coping style, which values represent mean scores.
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Bonferroni correction for multiple testing, whereas the 5-
HTTPLR LL effect did not (significance threshold P =
0.0125). The additive effect of homozygous L 5-HTTLPR
genotype appeared to be more pronounced in females
(OR 3.50, 95% CI 1.37-8.90) (Table 5), which was also
significant after Bonferroni correction for multiple testing
(significance threshold P = 0.0125).
Discussion
The results of this study suggest that patients carrying the
HTR3A c.-42T allele are at increased risk of having severe
dyspeptic symptoms. This risk seems to be even higher for
women and patients homozygous for the 5-HTTLPR L
allele.
The association could be explained as follows; Noxious
and non-noxious visceral sensations are carried by
extrinsic primary afferents to the dorsal horn of the
spinal cord. Sensory transmission in the spinal dorsal
horn is attenuated by endogenous inhibitory systems that
originate at the brainstem. One of the main descending
systems to the spinal dorsal horn is serotonergic [42]. 5-
HT3 receptors present on spinal inhibitory interneurons
receive input from the descending serotonergic fibers.
Activation of these 5-HT3 receptors evokes release of
GABA, which in turn reduces the excitability of dorsal
horn neurons [43]. Consequently, the output of visceral
sensory information to the brainstem and thereby symp-
tom perception is reduced. It has been demonstrated in a
model of visceral pain that 5-HT3 receptors in the spinal
cord mediate antinociception [44]. The HTR3A c.-42T
allele promotes translation of the HTR3A transcript
resulting in enhanced production of the 5-HT3A subunit
[27,28]. In vitro experiments indicate that homomeric
5-HT3A receptors have lower affinity for 5-HT and
desensitize more rapidly as compared to heteromeric 5-
HT3AB receptors [45]. Consistently, it has been found in
5-HTT knockout mice, in which 5-HT availability at the
receptor is enhanced, that the expression of 5-HT3 subu-
nits is altered, apparently leading to a relatively increased
proportion of homomeric 5-HT3A receptors [46]. Thus,
the increased expression of 5-HT3A subunits in HTR3A
c.-42T allele carriers may result in a higher proportion of
homomeric 5-HT3A receptors and as a consequence
decreased response to 5-HT of the 5-HT3 receptor
Table 3 Association of HTR3A c.-42C > T and 5-HTTLPR genotypes with dyspeptic symptom severity
Polymorphism Genotype Total N = 592 Severe dyspeptic symptoms OR (95% CI) * P value
Yes N = 197 No N = 395
HTR3A c.-42C>T CC 362 (61.1) 108 (54.8) 254 (64.3) 1.00 0.027
CT 200 (33.8)
TT 30 (5.1)
CT + TT 230 (38.9) 89 (45.2) 141 (35.7) 1.50 (1.06-2.20)
5-HTTLPR LL 170 (28.7) 59 (29.9) 111 (28.1) 1.00 0.60
LS 310 (52.4)
SS 112 (18.9)
LS + SS 422 (71.2) 138 (70.1) 284 (71.9) 0.90 (0.60-1.40)
Genotype distributions are depicted as number (%).
*adjusted for age, IBS status, psycho neuroticism, use of anti depressive and acid suppressive medication and active coping style.
Table 4 Association between severe dyspeptic symptoms and HTR3A c.-42C > T genotype stratified by gender and
5-HTTLPR genotype
Severe dyspeptic symptoms HTR3A c.-42C>T OR (95% CI) * P value
CC CT + TT
Gender
Female Yes 56 (49.6) 57 (50.4) 2.05 (1.25-3.39) 0.005
No 137 (65.6) 72 (34.4)
Male Yes 52 (61.9) 32 (38.1) 0.86
No 117 (62.9) 69 (37.1) 1.05 (0.60-1.84)
5-HTTLPR
LL Yes 31 (52.5) 28 (47.5) 2.00 (1.01-3.94) 0.046
No 77 (69.4) 34 (30.6)
LS + SS Yes 77 (55.8) 61 (44.2) 0.15
No 177 (62.3) 107 (37.7) 1.38 (0.88-2.15)
Genotype distributions are depicted as number (%).
*adjusted for age, IBS status, psycho neuroticism, use of anti depressive and acid suppressive medication and active coping style
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involved in the descending antinociceptive pathway
reflected in higher symptom severity. The additive effect
of the LL genotype of the 5-HTTLPR polymorphism is
conceivable as homozygosity for the long allele results in
more rapid re-uptake of 5-HT and earlier termination of
5-HT induced signalling. As a consequence activation of
the 5-HT3 receptor on inhibitory interneurons in the
spinal cord is even more diminished; this reduces
antinociception.
The association between severe dyspeptic symptoms
and the HTR3A c.-42C > T and 5-HTTLPR genotypes
appears to be stronger in females than in males. A possi-
ble explanation for this finding would be different avail-
ability of serotonin in males and females. It has been
shown that ovarian hormones regulate the expression of
tryptophan hydroxylase (rate-limiting enzyme of seroto-
nin synthesis), 5-HTT and inhibitory 5-HT1A autorecep-
tors [47]. Lack of control for the variations in female sex
hormones during the menstrual cycle, use of hormone
replacement therapy and hormonal contraception has
likely confounded many of the reported findings of gen-
der differences in indices of serotonin availability. Inter-
estingly, an in vivo investigation with positron emission
tomography and a-[11C]methyl-L-tryptophan trapping as
a proxy for brain serotonin synthesis, showed a lower
rate in healthy women compared to men [48]. Although
the pre-menopausal women were studied in the same
phase of the menstrual cycle, post-menopausal women
were also included. The latter may have affected the
extent of the reported difference in men and women.
Moreover, this finding in healthy subjects does not neces-
sarily reflect the situation in individuals with dyspepsia.
Anyhow, a lower rate of serotonin synthesis in women
coincides with a lower level of 5-HT available for recep-
tor activation in females, which is consistent with
reduced 5-HT3 receptor mediated antinociceptive effects.
In short, the presence of a 5-HT3 receptor with lower
response to 5-HT due to polymorphism, rapid 5-HT re-
uptake by 5-HTT and less serotonin available for recep-
tor activation due to gender differences in 5-HT synth-
esis predisposes to increased perception of visceral
stimuli. The influence of the HTR3A c.-42C > T geno-
type has also been evaluated in (female) patients with
irritable bowel syndrome (IBS) [30]. In contrast to what
one might expect, since both dyspeptic and IBS symp-
toms have a visceral sensitivity component, the CC gen-
otype appeared to be associated with greater IBS
severity. Enhanced activity of amygdala-related emo-
tional arousal circuits has been implicated in the patho-
physiology of IBS [49]. Consistent with a study in
healthy subjects, in IBS CC genotype subjects showed
increased amygdala responsiveness to emotional facial
stimuli compared with T carriers [30,41]. Activation of
5-HT3 receptors on GABAergic interneurons innervat-
ing the amygdala exerts an inhibitory influence on
amygdala reactivity, whereas those on excitatory inter-
neurons have the opposite effect [50]. The finding of
lower amygdala reactivity in T carriers was interpreted
as T-allele-related increased expression of 5-HT3 recep-
tors on GABAergic interneurons resulting in greater
inhibition of the amygdala [30,41] These associations
and interpretation of increased 5-HT3A subunit expres-
sion appear in conflict with our findings, but 5-HT3
receptor subunit composition may vary in the different
regions of the central nervous system as well as the
influence of 5-HT3 receptors on excitatory interneurons.
Moreover, in dyspepsia increased amygdala responsive-
ness may be secondary to decreased spinal antinocicep-
tion. It is noteworthy that another study in patients with
IBS suggests that the HTR3A c.-42T allele is associated
with the diarrhea-predominant phenotype of the disease
[28]. Patients with this phenotype seem to be more
often affected by visceral hypersensitivity [51]. Further-
more, the HTR3A c.-42T allele was found to be asso-
ciated with visceral hypersensitivity in patients with
gastroesophageal reflux disease [52].
Table 5 Association between severe dyspeptic symptoms and HTR3A c.-42C > T genotype stratified by 5-HTTLPR
genotype in females and males
Gender 5-HTTLPR Severe dyspeptic symptoms HTR3A c.-42C>T OR (95% CI) P value
CC CT + TT
Female LL Yes 16 (45.7) 19 (54.3) 3.50 (1.37-8.90) 0.009
No 45 (75.0) 15 (25.0)
LS + SS Yes 40 (51.3) 38 (48.7) 0.090
No 92 (61.7) 57 (38.3) 1.70 (0.93-3.14)
Male LL Yes 15 (62.5) 9 (37.5) 0.96 (0.32-2.89) 0.94
No 32 (63.0) 19 (37.0)
LS + SS Yes 37 (62.0) 23 (38.0) 0.66
No 85 (63.0) 50 (37.0) 1.16 (0.59-2.28)
Genotype distributions are depicted as number (%).
*adjusted for age, IBS status, psycho neuroticism, use of anti depressive and acid suppressive medication and active coping style
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The HTR3A c.-42C > T polymorphism likely represents
a predisposing genetic variant in common to psychiatric
disorders and dyspepsia. Recently, effects of the HTR3A
c.-42C > T genotype on emotional brain correlates of sus-
ceptibility to depression have been reported [53]. Further-
more, in healthy subjects and patients with IBS the CC
genotype was found to be associated with greater anxiety
ratings [30] and in Caucasians the C-allele was associated
with elevated scores for the anxiety-related trait harm
avoidance [29]. Although anxiety is comorbid with dys-
pepsia, our findings indicate that in dyspepsia the opposite
allele is associated with greater overall symptom severity.
Additional research is needed to directly examine the rela-
tionship between HTR3A c.-42C > T polymorphism and
anxiety in patients with dyspepsia.
To appreciate results of this study several limitations
should be mentioned. To date, most studies on 5-HT3
receptor composition and function have been performed
in vitro or in rodents, which lack expression of the
HTR3C, D, and E subunits [26]. It is not known yet how
native receptors in humans are composed, including the
5-HT3 receptors on spinal inhibitory interneurons. Also
the consequences of increased expression of 5-HT3A sub-
units for receptor composition and antinociceptive func-
tion have not been assessed in vivo. Secondly, there is a
possibility that association between HTR3A c.-42T allele
and severe dyspeptic symptoms is due to the effect of
some other polymorphism, even in another gene, which is
in linkage disequilibrium with HTR3A c.-42C > T. Indeed,
the serotonin receptor subunit gene HTR3B maps in close
proximity to HTR3A and the possibility has been raised
that the HTR3A c.-42C > T polymorphism is not the sus-
ceptibility variant but a common variant in HTR3B, found
to be associated with depression in Japanese [54]. Further-
more, we could not discriminate between patients with
organic and functional dyspepsia. This could influence the
results if the association would be specific only for one of
them. In this respect it has to be mentioned that pre-
viously no significant association of HTR3A c.-42C > T
and 5-HTTLPR polymorphisms with dyspeptic symptoms
was detected in tertiary referral patients [17]. In the latter
study organic disease was excluded, but we believe that
the discrepant results can be explained by taking into
account not merely the presence but also the severity of
dyspeptic symptoms in the current study.
Conclusions
The results of this study suggest that there is an associa-
tion between HTR3A c.-42T allele and severe dyspeptic
symptoms. Altered 5-HT3 receptor function alone or in
combination with 5-HTTLPR genotype could explain
symptom severity in a subgroup of patients. The associa-
tions may be explained by the increased susceptibility to
visceral hypersensitivity of the gastrointestinal tract and/or
increased risk of having psychiatric comorbidity. Further
research will have to replicate this result and clarify the
clinical consequences of it.
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